The latest generation of nanopharmaceutical
NANOFACTURING will design and build pilot and large scale manufacturing lines for the production of nanopharmaceuticals. The project will focus on the scale up of glycan-coated gold nanoparticles, the latest generation of nanomedicines.
A number of nanopharmaceutical formulations have been shown to hold considerable potential for enabling more effective and less toxic therapeutic interventions. However, progress to date in translating these initiatives to commercial success has been limited.
Nanofacturing aims to address the bottlenecks in the delivery of these medicines to the market.Find out more